ASTELLAS PHARMA INC./ JP3942400007 /
| 2024-05-24 10:59:59 PM | Chg. +0.070 | Volume | Bid10:59:59 PM | Ask10:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.146EUR | +0.77% | - Turnover: - |
9.146Bid Size: - | 9.330Ask Size: - | 18 bill.EUR | - | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 54.24 JPY | -19.14% |
| EPS Diluted: | - JPY | -19.33% |
| Revenues per Share: | 845.20 JPY | 19.14% |
| Book Value per Share: | 839.26 JPY | 5.00% |
| Cash Flow per Share: | 182.42 JPY | 29.46% |
| Dividend per Share: | 60.00 JPY | 20.00% |
| Total | in mill. | |
| Revenues: | 1,518,619.00 JPY | 17.16% |
| Net Income: | 98,714.00 JPY | -20.45% |
| Operating Cash Flow: | 327,767.00 JPY | - |
| Cash and Cash Equivalents: | 376,840.00 JPY | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 28.86 | 34.72 |
| P/S Ratio: | 1.85 | 2.23 |
| P/BV ratio: | 1.87 | 2.24 |
| P/CF Ratio: | 8.58 | 10.32 |
| PEG: | -1.51 | -1.81 |
| Earnings Yield: | 3.46% | 2.88% |
| Dividend Yield: | 3.83% | 3.19% |
| Market Capitalization | ||
| Market Capitalization: | 18 bill. EUR | 24.02 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 1.24 mill. EUR | 1.66 mill. EUR |
| Shares Outstanding: | 1.8 bill. | |
Profitability
| Gross Profit Margin: | 81.01% |
| EBIT Margin: | 8.76% |
| Net Profit Margin: | 6.50% |
| Return on Equity: | 6.55% |
| Return on Assets: | 4.02% |
Financial Strength
| Liquidity I / Cash Ratio: | 51.90% |
| Liquidity II / Quick Ratio: | 114.18% |
| Liquidity III / Current Ratio: | 144.62% |
| Debt / Equity Ratio: | 62.90% |
| Dynam. Debt / Equity Ratio: | 289.40% |
Efficiency
| Employees: | 14,480 |
| Personal Expenses / Employee: | - JPY |
| Revenues / Employee: | 104,877,002.76 JPY |
| Net Income / Employee: | 6,817,265.19 JPY |
| Total Assets / Employee: | 169,649,033.15 JPY |
| * Fiscal Year End: | 2023-03-31 |
| Accounting Standard: | IFRS |
| Currency: | JPY |
